1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. 細胞タイプ別スニペット
3.3. 用途別スニペット
3.4. エンドユーザー別スニペット
3.5. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 慢性疾患の増加
4.1.1.2. デバイスの進歩
4.1.2. 阻害要因
4.1.2.1. 細胞生物学に関する倫理的懸念
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. 特許分析
5.6. PESTLE分析
5.7. SWOT分析
5.8. DMI意見
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 製品タイプ別市場規模分析および前年比成長率分析(%)
6.1.2. 市場魅力度指数（製品タイプ別
6.2. 自動細胞培養システム
6.2.1. 序論
6.3. 装置
6.4. 消耗品
6.5. バイオリアクター
7. 細胞タイプ別
7.1. はじめに
7.1.1. 細胞タイプ別市場規模分析および前年比成長率分析（%） 7.1.1.
7.2. 市場魅力度指数（セルタイプ別
7.3. 動物細胞
7.3.1. はじめに
7.3.2. 市場規模分析と前年比成長率分析(%)
7.4. ヒト細胞
7.5. 幹細胞（SC）
7.6. 成体幹細胞
7.7. その他
8. 用途別
8.1. 導入
8.1.1. 市場規模分析および前年比成長率分析（%）, アプリケーション別
8.2. 市場魅力度指数、用途別
8.3. 再生医療と幹細胞研究
8.3.1. はじめに
8.3.2. 市場規模分析と前年比成長率分析(%)
8.4. 臨床研究
8.5. ワクチン生産
8.6. その他
9. エンドユーザー別
9.1. 導入
9.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
9.1.2. 市場魅力度指数、エンドユーザー別
9.2. バイオ医薬品・バイオテクノロジー企業
9.2.1. はじめに
9.2.2. 市場規模分析と前年比成長率分析(%)
9.3. 研究機関
9.4. 病院
9.5. 診断研究所
9.6. その他
10. 地域別
10.1. はじめに
10.1.1. 地域別市場規模分析および前年比成長率分析(%)
10.1.2. 市場魅力度指数、地域別
10.2. 北米
10.2.1. 序論
10.2.2. 主な地域別ダイナミクス
10.2.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.2.4. 市場規模分析およびYoY成長率分析（%）、セルタイプ別
10.2.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
10.2.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.2.7. 市場規模分析および前年比成長率分析(%)、国別
10.2.7.1. 米国
10.2.7.2. カナダ
10.2.7.3. メキシコ
10.3. ヨーロッパ
10.3.1. はじめに
10.3.2. 主な地域別ダイナミクス
10.3.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.3.4. 市場規模分析およびYoY成長率分析（%）、セルタイプ別
10.3.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
10.3.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.3.7. 市場規模分析および前年比成長率分析(%)、国別
10.3.7.1. ドイツ
10.3.7.2. イギリス
10.3.7.3. フランス
10.3.7.4. イタリア
10.3.7.5. スペイン
10.3.7.6. その他のヨーロッパ
10.4. 南米
10.4.1. はじめに
10.4.2. 地域別主要市場
10.4.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.4.4. 市場規模分析およびYoY成長率分析（%）、セルタイプ別
10.4.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
10.4.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.4.7. 市場規模分析および前年比成長率分析(%)、国別
10.4.7.1. ブラジル
10.4.7.2. アルゼンチン
10.4.7.3. その他の南米諸国
10.5. アジア太平洋
10.5.1. 序論
10.5.2. 主な地域別ダイナミクス
10.5.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.5.4. 市場規模分析およびYoY成長率分析（%）、セルタイプ別
10.5.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
10.5.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.5.7. 市場規模分析および前年比成長率分析（%）, 国別
10.5.7.1. 中国
10.5.7.2. インド
10.5.7.3. 日本
10.5.7.4. 韓国
10.5.7.5. その他のアジア太平洋地域
10.6. 中東・アフリカ
10.6.1. 序論
10.6.2. 主な地域別ダイナミクス
10.6.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.6.4. 市場規模分析およびYoY成長率分析（%）、セルタイプ別
10.6.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
10.6.6. 市場規模分析および前年比成長率分析（%）：エンドユーザー別
11. 競合情勢
11.1. 競争シナリオ
11.2. 市場ポジショニング／シェア分析
11.3. M&A分析
12. 企業プロフィール
12.1. Thermo Fisher Scientific, Inc*
12.1.1. 会社概要
12.1.2. 製品ポートフォリオと内容
12.1.3. 財務概要
12.1.4. 主な展開
12.2. Merck KGaA
12.3. Becton, Dickinson and Company
12.4. GE Healthcare
12.5. Terumo BCT
12.6. Beckman Coulter Inc
12.7. Miltenyi Biotec
12.8. Stemcell Technologies, Inc.
12.9. Takara Bio Inc.
12.10. Lnza Group LTD(*リストは除く)
13. 付録
13.1. 会社概要とサービス
13.2. お問い合わせ
Global Cell Expansion Market reached US$ 20 billion in 2023 and is expected to reach US$ 55 billion by 2031, growing at a CAGR of 15.3% during the forecast period 2024-2031.
Cell expansion is the process of culturing isolated cells for multiple generations to achieve the desired number of cells for a regenerative response in a patient. This involves serial passages in closed culture vessels and the use of culture medium to remove metabolites and provide nutrients.
Moreover, cell expansion is a crucial process in biotechnology and regenerative medicine, aiming to increase the quantity of specific cell types for therapeutic applications. It is essential for developing cell-based therapies, such as stem cells and immune cells, which require large numbers of cells. Cell expansion's significance lies in producing functional cells for cancer immunotherapy, tissue engineering, and regenerative medicine.
Market Dynamics: Drivers & Restraints
Rise in the prevalence of chronic diseases
The global cell expansion market is expanding due to the rise in chronic diseases like cancer, diabetes, and autoimmune disorders. This has led to a demand for advanced therapies like regenerative medicine, cell-based therapies, and personalized treatments. Cell expansion is crucial for developing these treatments, and healthcare providers and researchers are seeking innovative solutions to meet the global need for effective treatment options.
For instance, in 2023, according to Institute for Health Metrics and Evaluation, Diabetes affects over half a billion people globally, affecting men, women, and children of all ages. The number is projected to double to 1.3 billion in the next 30 years, with every country experiencing an increase. The global prevalence rate is 6.1%, making diabetes one of the top 10 leading causes of death and disability. North Africa and the Middle East have the highest rate at 9.3%, which is projected to rise to 16.8% by 2050.
Ethical concern related to cell biology
Ethical concerns in cell biology are limiting the cell expansion market. The use of embryonic stem cells, which involve human embryo destruction, has led to restrictions in many countries. Adult stem cells, an ethical alternative, often involve invasive procedures, raising concerns about patient consent and safety. Genetically modified cells pose potential risks to patients and the environment. These ethical concerns are hindering the growth of the cell expansion market.
Market Segment Analysis
The global cell expansion market is segmented based on product type, cell type, application, end user and region.
The instruments from the product type segment accounted for approximately 41.3% of the cell expansion market share
The instruments from the product type segment accounted for approximately 41.3%. Instruments are crucial in cell expansion, enabling controlled growth and multiplication for therapeutic and research purposes. Automated bioreactors, cell counters, centrifuges, and incubators maintain optimal conditions during cell culture, ensuring consistency, scalability, and efficiency. These devices are essential for regenerative medicine, immunotherapy, and tissue engineering. Advanced instrumentation improves cell viability and yield reduces contamination risks, and produces high-quality cells for clinical use.
For instance, in September 2024, 10x Genomics, Inc. launched Chromium Xo, a new single cell instrument designed for researchers seeking high-quality data on limited budgets. This affordable entry point into routine, high-performance single cell analysis is part of its fleet of Chromium single cell instruments.
Market Geographical Share
North America is estimated to hold about 38.4% of the total market share throughout the forecast period
North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to rising cancer incidence, increased government funding, research on stem cell therapies, and increased awareness of advanced treatment methods.
For instance, in October 2024, Aspen Neuroscience, Inc., a private biotechnology company developing personalized (autologous) cell therapies, announced the expansion of its San Diego footprint near its headquarters in Torrey Pines, with a new 22,000 square foot facility for GMP manufacturing of induced pluripotent stem cell (iPSC)-derived cell therapies.
Moreover, in August 2024, Pluri Inc has been granted a US patent for a new method for expanding immune cells using proprietary 3D cell expansion technology. This technology mimics the natural lymph node-like environment of immune cells within the human body, providing cells with the necessary conditions for efficient expansion at scale and quality.
Market Segmentation
By Product Type
Automated Cell Expansion Systems
Instruments
Cell Expansion Supporting Equipment
Cell Counters
Flow Cytometers
Centrifuges
Other Supporting Equipment
Others
Consumables
Reagents
Media
Disposables
Tissue Culture Flasks
Others
Bioreactors
Microcarrier Bioreactors
Microcarrier-based anchorage-dependent bioreactors
Suspension-based anchorage-independent bioreactors
Perfusion/Hollow Fibre Bioreactors
By Cell Type
Animal Cells
Human Cells
Stem Cells (SCs)
Adult Stem Cells
Others
By Application
Regenerative Medicine and Stem Cell Research
Clinical Studies
Vaccine Production
Others
By End User
Biopharmaceutical & Biotechnology Companies
Research Institutes
Hospitals
Diagnostic Laboratories
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Competitive Landscape
The major global players in the market include Thermo Fisher Scientific, Inc, Merck KGaA, Becton, Dickinson and Company, GE Healthcare, Terumo BCT, Beckman Coulter Inc, Miltenyi Biotec, Stemcell Technologies, Inc., Takara Bio Inc., Lnza Group LTD among others.
Key Developments
In August 2024, HC Corporation Biomedical Division showcased a prototype of its new cell expansion system, LiCellGrow, at the ISCT Europe 2024 Regional Meeting in Gothenburg, Sweden. LiCellGrow allows pharmaceutical companies to visualize real-time metabolic changes in cells and automatically adjust cell culture conditions for optimal growth. It aims to increase the availability of cell and gene therapy products by accelerating the manufacturing of specific cells needed for these therapies.
In March 2024, Getinge has partnered with the bioprocessing company CellRev in the development of a continuous cell processing platform called Livit ACE (Adherent Cell Expansion). The solution is a breakthrough within allogenic cell therapy manufacturing.
Why Purchase the Report?
To visualize the global cell expansion
Market Segmentation based on product type, cell type, application, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the cell expansion market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.
The global cell expansion market report would provide approximately 64 tables, 61 figures and 186 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Cell Type
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the prevalence of chronic diseases
4.1.1.2. Rise in the advancements of devices
4.1.2. Restraints
4.1.2.1. Ethical concern related to cell biology
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Automated Cell Expansion Systems*
6.2.1. Introduction
6.3. Instruments
6.4. Consumables
6.5. Bioreactors
7. By Cell Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
7.2. Market Attractiveness Index, By Cell Type
7.3. Animal Cells*
7.3.1. Introduction
7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.4. Human Cells
7.5. Stem Cells (SCs)
7.6. Adult Stem Cells
7.7. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2. Market Attractiveness Index, By Application
8.3. Regenerative Medicine and Stem Cell Research*
8.3.1. Introduction
8.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.4. Clinical Studies
8.5. Vaccine Production
8.6. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Biopharmaceutical & Biotechnology Companies*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Research Institutes
9.4. Hospitals
9.5. Diagnostic Laboratories
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Thermo Fisher Scientific, Inc*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Merck KGaA
12.3. Becton, Dickinson and Company
12.4. GE Healthcare
12.5. Terumo BCT
12.6. Beckman Coulter Inc
12.7. Miltenyi Biotec
12.8. Stemcell Technologies, Inc.
12.9. Takara Bio Inc.
12.10. Lnza Group LTD (*LIST NOT EXHAUSTIVE)
13. Appendix
13.1. About Us and Services
13.2. Contact Us
*** 細胞増殖の世界市場に関するよくある質問(FAQ) ***
・細胞増殖の世界市場規模は？
→DataM Intelligence社は2023年の細胞増殖の世界市場規模を200億米ドルと推定しています。
・細胞増殖の世界市場予測は？
→DataM Intelligence社は2031年の細胞増殖の世界市場規模を550億米ドルと予測しています。
・細胞増殖市場の成長率は？
→DataM Intelligence社は細胞増殖の世界市場が2024年～2031年に年平均15.3%成長すると展望しています。
・世界の細胞増殖市場における主要プレイヤーは？
→「Thermo Fisher Scientific, Inc.、Merck KGaA、Becton, Dickinson and Company、GE Healthcare、Terumo BCT、Beckman Coulter Inc.、Miltenyi Biotec、Stemcell Technologies, Inc.、Takara Bio Inc.、Lnza Group LTDなど ...」を細胞増殖市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
